Captain Chesley "Sully" Sullenberger and wife Lorrie reveal the subtle behavioral shifts noticed years before his Alzheimer's ...

Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

Capt. Chesley "Sully" Sullenberger revealed his greatest concern after his Alzheimer's disease diagnosis is that this is his ...

For the first time since announcing his Alzheimer’s diagnosis over the summer, Capt. Sully Sullenberger discusses the impact on his life.

Even with preserved memory, older adults with higher amyloid-beta levels face greater risks of future brain atrophy. A new ...

This phase 2b/3, double-blind trial of oral Xanamem in 247 participants with mild to moderate Alzheimer’s disease and elevated pTau181 evaluates the potential benefit of targeting excess cortisol in ...

When the brain's cellular recycling system breaks down in Alzheimer's disease, damaged mitochondria pile up inside nerve fibers. Researchers have now identified these clusters as "mitochondrial ...

“I’ve gone through harder things than this before,” the “Miracle on the Hudson” pilot says as he opens up about living with ...

Research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative launched in ...

Health headlines for Wednesday, Sept. 23 include GLP-1 vision loss lawsuits, a new Alzheimer's brain map and ibogaine under ...

In mice whose brains accumulate clumps of tau protein, researchers found a way to protect nerve cells without clearing away those clumps. They interrupted an immune response directed from outside the ...

For a long time, dementia research has been shaped by concerns that participation may be too burdensome for people with ...